Taxol 30mg / 5ml. 100mg / 5ml. 300mg / 50ml Infusion
PDF Leaflet Revision Date: 02 April 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Palliative treatment of advanced ovarian, breast, and lung cancers.
Dosage (summary)
175 mg/mu00b2 IV over 3 hours every 3 weeks; adjust for neutrophil count.
Special Populations
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy; avoid breastfeeding during therapy.
Key Drug Interactions
- Ketoconazole may inhibit metabolism
- Increased doxorubicin levels when combined
Contraindications
- Severe hypersensitivity to TAXOL
- Neutrophils < 1500/mmu00b3
Common side effects
- Neutropenia
- Peripheral neuropathy
- Hypersensitivity reactions
- Nausea
- Vomiting
Counselling Points
- Premedicate with corticosteroids and antihistamines
- Monitor for hypersensitivity reactions
- Avoid pregnancy during treatment
Serious warnings
- Severe hypersensitivity reactions possible
- Bone marrow suppression
- Cardiac conduction abnormalities
Important Disclaimer
The Taxol 30mg / 5ml. 100mg / 5ml. 300mg / 50ml Infusion professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
